1. Home
  2. VERU vs HKIT Comparison

VERU vs HKIT Comparison

Compare VERU & HKIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • HKIT
  • Stock Information
  • Founded
  • VERU 1971
  • HKIT 1996
  • Country
  • VERU United States
  • HKIT China
  • Employees
  • VERU N/A
  • HKIT N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • HKIT Computer Software: Prepackaged Software
  • Sector
  • VERU Health Care
  • HKIT Technology
  • Exchange
  • VERU Nasdaq
  • HKIT Nasdaq
  • Market Cap
  • VERU 54.6M
  • HKIT 54.8M
  • IPO Year
  • VERU 1990
  • HKIT 2023
  • Fundamental
  • Price
  • VERU $3.75
  • HKIT $2.16
  • Analyst Decision
  • VERU Strong Buy
  • HKIT
  • Analyst Count
  • VERU 3
  • HKIT 0
  • Target Price
  • VERU $33.33
  • HKIT N/A
  • AVG Volume (30 Days)
  • VERU 139.0K
  • HKIT 35.1K
  • Earning Date
  • VERU 12-15-2025
  • HKIT 04-08-2026
  • Dividend Yield
  • VERU N/A
  • HKIT N/A
  • EPS Growth
  • VERU N/A
  • HKIT N/A
  • EPS
  • VERU N/A
  • HKIT N/A
  • Revenue
  • VERU $16,886,419.00
  • HKIT $1,812,901.00
  • Revenue This Year
  • VERU N/A
  • HKIT N/A
  • Revenue Next Year
  • VERU N/A
  • HKIT N/A
  • P/E Ratio
  • VERU N/A
  • HKIT N/A
  • Revenue Growth
  • VERU 337.24
  • HKIT N/A
  • 52 Week Low
  • VERU $2.64
  • HKIT $1.15
  • 52 Week High
  • VERU $14.20
  • HKIT $2.41
  • Technical
  • Relative Strength Index (RSI)
  • VERU 47.71
  • HKIT 67.50
  • Support Level
  • VERU $3.61
  • HKIT $2.00
  • Resistance Level
  • VERU $3.99
  • HKIT $2.41
  • Average True Range (ATR)
  • VERU 0.30
  • HKIT 0.16
  • MACD
  • VERU -0.10
  • HKIT 0.02
  • Stochastic Oscillator
  • VERU 14.52
  • HKIT 58.79

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About HKIT Hitek Global Inc.

Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.

Share on Social Networks: